Latest filing published 03 Oct 2014 for Molecular Templates, Inc., €8,949.
First 200 filings with a declared amount
No signal scores available.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of David L. Anderson across 8 companies, led by Mattersight Corp, Dionex Corp /DE and Cardica Inc. Between 8 February 2006 and 1 October 2014, the trades on record add up to 341 filings.
On the open market, the record shows 129 purchases worth €8.5M and 135 sales worth €20.9M. Taken together, the sales exceed the purchases by €12.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 27 share grants and 3 option exercises. 2014 to date brings no purchases and 8 sales.
The median purchase comes to €10k. Ninety days after publication, 6 purchases show a median change of +5.3%, with the price up in 67% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 3 October 2014, reports a share grant of €677k in Molecular Templates, Inc. The clock since the last published purchase (5 December 2013) now reads 4,705 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 245 declarations